Cell based approaches for myocardial regeneration and artificial myocardium

Current Stem Cell Research and Therapy

Volumn 2, Issue 2, 2007, Pages 121-127

  Genovese, Jorge ^a   Cortes Morichetti, Miguel ^b   Chachques, Emmanuel ^a   Frati, Giacomo ^b   Patel, Amit ^a   Chachques, Juan C ^b  

^a UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

^b HÔPITAL EUROPÉEN GEORGES POMPIDOU   (France)

Author keywords

Artificial myocardium; Cardiomyopathy; Cellular cardiomyoplasty; Heart failure; Ischemic heart disease; Stem cell transplantation; Tissue engineering

Indexed keywords

ALDOSTERONE ANTAGONIST; ALGINIC ACID; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BIOMATERIAL; COLLAGEN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ELASTOMER; FIBRIN; GELATIN; POLY(3 HYDROXYBUTYRIC ACID); POLYCAPROLACTONE; POLYGLYCOLIC ACID; POLYLACTIC ACID; POLYURETHAN; POLYVINYL ALCOHOL;

AGING; ANGIOGENESIS; ARTIFICIAL HEART; BIOARTIFICIAL ORGAN; BIOPHYSICS; BLOOD VESSEL COMPLIANCE; CARDIAC RESYNCHRONIZATION THERAPY; CELL CULTURE; CELL TYPE; CLINICAL TRIAL; CONGESTIVE CARDIOMYOPATHY; CRYOPRESERVATION; CYTOLOGY; ELECTROPHYSIOLOGY; ELECTROSTIMULATION; FINANCIAL MANAGEMENT; GENETICS; GOOD MANUFACTURING PRACTICE; HEART FAILURE; HEART INFARCTION; HEART MUSCLE; HEART MUSCLE CONTRACTILITY; HEART MUSCLE ISCHEMIA; HEART TRANSPLANTATION; HUMAN; MOLECULAR BIOLOGY; PRIORITY JOURNAL; PUBLIC HEALTH PROBLEM; REVIEW; STEM CELL TRANSPLANTATION; TISSUE ENGINEERING; TISSUE REGENERATION;

BIOARTIFICIAL ORGANS; HUMANS; MYOCARDIUM; REGENERATION; STEM CELLS; TISSUE ENGINEERING; TISSUE THERAPY;

EID: 34249342307     PISSN: 1574888X     EISSN: None     Source Type: Journal    
DOI: 10.2174/157488807780599239     Document Type: Review

References (65)

1. Jessup M, Brozena S. Heart failure. N Engl J Med 2003; 348: 2007-2018.
2. Bleumink GS, Knetsch AM, Sturkenboom MC, et al. Quantifying the heart failure epidemic: prevalence, incidence rate, lifetime risk and prognosis of heart failure The Rotterdam Study. Eur Heart J 2004; 25: 1614-9.
3. Chachques JC, Abdel Shafy AB, Duarte F, et al. From dynamic to cellular cardiomyoplasty. J Card Surg 2002; 17: 194-200.
4. Chacliques JC, Acar C, Herreros J, et al. A. Cellular cardiomyoplasty: clinical application. Ann Thorac Surg 2004; 77: 1121-30.
5. Pfeffer MA, Braunwald E. Ventricular remodeling after myocardial infarction. Experimental observations and clinical implications. Circulation 1990; 81: 1161-72.
6. Wang JS, Shum-Tim D, Galipeau J, et al. Marrow stromal cells for cellular cardiomyoplasty: feasibility and potential clinical advantages. J Thorac Cardiovasc Surg 2000; 120: 999-1005.
7. Rajnoch C, Chachques JC, Berrebi A. et al. A. Cellular therapy reverses myocardial dysfunction. J Thorac Cardiovasc Surg 2001; 121: 871-8.
8. Verfaillie CM, Schwartz R, Reyes M, et al. Unexpected potential of adult stem cells. Ann N Y Acad Sci 2003; 996: 231-4.
9. Chachques JC, Cattadori B, Herreros J, et al. Treatment of heart failure with autologous skeletal myoblasts. Herz 2002; 27: 570-8.
10. Haider HK, Tan AC, Aziz S, et al. Myoblast transplantation for cardiac repair: a clinical perspective. Mol Ther 2004; 9: 14-23.
11. Vilas-Boas F, Feitosa GS, Soares MB, et al Bone marrow cell transplantation to the myocardium of a patient with heart failure due to Chagas' disease. Arq Bras Cardiol 2004; 82: 185-7.
12. Perin EC, Dohmann HF, Borojevic R, et al. Transendocardial, autologous bone marrow cell transplantation for severe, chronic ischemic heart failure, Circulation 2003; 107: 2294-302.
13. Chachques JC, Herreros J, Trainini J, et al. Autologous human serum for cell culture avoids the implantation of cardioverter-defibrillators in cellular cardiomyoplasty. Int J Cardiol 2004; 95 (Suppl 1): S29-S33.
14. Stamm C, Westphal B, Kleine HD, et al. Autologous bone-marrow stem-cell transplantation for myocardial regeneration. Lancet 2003; 361: 45-6.
15. Schachinger V, Assmus B, Britten MB, et al. Transplantation of progenitor cells and regeneration enhancement in acute myocardial infarction: final one-year results of the TOPCARE-AMI Trial. J Am Coll Cardiol 2004; 44: 1690-9.
16. Narmoneva DA, Vukmirovic R, Davis ME, et al. Endothelial cells promote cardiac myocyte survival and spatial reorganization. Implications for cardiac regeneration. Circulation 2004; 110: 962-968.
17. Elmadbouh I, Chen Y, Louedec L, et al. Mesothelial cell transplantation in the infarct scar induces neovascularization and improves heart function. Cardiovasc Res 2005; 68: 307-17.
18. Planat-Benard V, Menard C, Andre M, Puceat M, et al. Spontaneous cardiomyocyte differentiation from adipose tissue stroma cells. Circ Res 2004; 94: 223-9.
19. Kehat I, Khimovich L, Caspi O, et al. Electromechanical integration of cardiomyocytes derived from human embryonic stem cells. Nat Biotechnol 2004; 22: 1282-9.
20. Cortes-Morichetti M, Frati G, Schussler O, et al. Association of bioartificial myocardium and cellular cardiomyoplasty for myocardial support and regeneration. Circulation 2005; 112 (Suppl II): II-741.
21. Eschenhagen T, Zimmermann WH. Engineering myocardial tissue. Circ Res 2005; 97: 1220-31.
22. Kofidis T, Akhyari P, Boublik J, et al. In vitro engineering of heart muscle: artificial myocardial tissue. J Thorac Cardiovasc Surg 2002; 124: 63-69.
23. Leor J, Cohen S. Myocardial tissue engineering: creating a muscle patch for a wounded heart. Ann NY Acad Sci 2004; 1015: 312-319.
24. Chachques JC, Trainini JC, Lago N, et al. Myocardial Assistance by Grafting a New bioartificial Upgraded Myocardium (MAGNUM Trial): Clinical feasibility study. Circulation 2006; 114(Suppl. II): II-566.
25. Hierlihy AM, Seale P, Lobe CG, et al. The post-natal heart contains a myocardial stem cell population. FEBS Lett 2002; 530: 239-243.
26. Linke A, Muller P, Nurzynska D, et al. Stem cells in the dog heart are self-renewing, clonogenic, and multipotent and regenerate infracted myocardium, improving cardiac function. PNAS 2005; 102: 8966-8971
27. Matsuura K, Nagai T, Nishigaki N, et al. Adult cardiac sca-1-positive cells differentiate into beating cardiomyocytes. J Biol Chem 2004; 279: 11384-11391.
28. Oh H, Bradfute SB, Gallardo TD, et al. Cardiac progenitor cells from adult myocardium: homing, differentiation, and fusion after infarction. Proc Natl Acad Sci USA 2003; 100: 12313-12318.
29. Urbanek K, Quaini F, Tasca G, et al. Intense myocyte formation from cardiac stem cells in human cardiac hypertrophy. Proc Natl Acad Sci USA 2003; 100: 10440-10445.
30. Pellegrini G, Dellambra E, Golisano O et al. p63 identifies keratinocyte stem cells. Proc Natl Acad Sci USA 2001; 98: 3156-3161
31. Jaffredo T, Nottingham W, Liddiard Y, et al. From hemangioblast to hematopoietic stem cell: an endothelial connection? Exp Hematol 2005; 33: 1029-1040.
32. Sanai N, Alvarez-Buylla A, Berger MS. Neural stem cells and the origin of gliomas. N Engl J Med 2005; 353: 811-822
33. Messina E, De Angelis L, Frati G, et al. Isolation and expansion of adult cardiac stem cells from human and murine heart. Circ Res 2004; 95: 911-921.
34. Poss KD, Wilson LG, Keating MT. Heart regeneration in zebrafish. Science 2002; 298: 2188-2190.
35. Bettencourt-Dias M, Mittnacht S, Brockes JP. Heterogeneous proliferative potential in regenerative adult newt cardiomyocytes. J Cell Sci 2003; 116, 4001-4009.
36. Tang YL, Zhao Q, Qin X, et al. Paracrine action enhances the effects of autologous mesenchymal stem cell transplantation on vascular regeneration in rat model of myocardial infarction. Ann Thorac Surg 2005; 80: 229-236.
37. Singla DK, Hacker TA, Ma L, et al. Transplantation of embryonic stem cells into the infarcted mouse heart: formation of multiple cell types. J Mol Cell Cardiol 2006; 40: 195-200.
38. Smits PC, van Geuns RJ, Poldermans D, et al. Catheter-based intramyocardial injection of autologous skeletal myoblasts as a primary treatment of ischemic heart failure: clinical experience with six-month follow-up. J Am Coll Cardiol 2003; 42: 2063-9.
39. Menasche P, Hagege AA, Vilquin JT, et al. Autologous skeletal myoblast transplantation for severe postinfarction left ventricular dysfunction. J Am Coll Cardiol 2003; 41: 1078-83.
40. Chachques JC, El Serafi M, Azarine A, et al. Ex-vivo MRI evaluation of local myocardial treatments: comparison between epicardial and endocardial (Cell-Fix catheter) injection. Circulation 2005; 112 (Suppl II): II-750.
41. Davis ME, Motion M, Narmoneva DA, et al. Injectable self-assembling peptide nanofibers create intramyocardial microenvironments for endothelial cells. Circulation 2005; 111: 442-450
42. Hsieh PC, Davis ME, Gannon J, et al. Controlled delivery of PDGF-BB for myocardial protection using injectable self-assembling peptide nanofibers. J Clin Invest 2006; 116: 237-248.
43. Davis ME, Hsieh PC, Grodzinsky AJ, et al. Custom design of the cardiac microenvironment with biomaterials. Circ Res 2005; 97: 8-15.
44. Chachques JC, Salanson-Lajos C, Lajos P, et al. Cellular cardiomyoplasty for myocardial regeneration. Asian Cardiovasc Thorac Ann 2005; 13: 287-96.
45. Radisic M, Park H, Shing H, et al. Functional assembly of engineered myocardium by electrical stimulation of cardiac myocytes cultured on scaffolds. Proc Natl Acad Sci USA 2004; 101: 18129-34.
46. Chachques JC. Method of providing a dynamic cellular cardiac support. United States Patents A2002 0124855, A2005 0002912. (http://www.uspto.gov)
47. Chachques JC, Shafy A, Cattadori B, et al. Electrostimulation enhanced fatigue resistant myosin expression in cellular cardiomyoplasty. Circulation 2001; 104 (Suppl. 2): 555-556.
48. Chachques JC, Argyriadis PG, Fontaine G, et al. Right ventricular cardiomyoplasty: 10-year follow-up. Ann Thorac Surg 2003; 75: 1464-8
49. Stevenson LW, Miller LW, Desvigne-Nickens P, et al. REMATCH Investigators. Left ventricular assist device as destination for patients undergoing intravenous inotropic therapy: a subset analysis from REMATCH (Randomized Evaluation of Mechanical Assistance in Treatment of Chronic Heart Failure). Circulation 2004; 110: 975-81.
50. Chachques JC, Duarte F, Cattadori B, et al. Angiogenic growth factors and/or cellular therapy for myocardial regeneration: a comparative study. J Thorac Cardiovasc Surg 2004; 128: 245-53.
51. Losordo DW, Dimmeler S. Therapeutic angiogenesis and vasculogenesis for ischemic disease. Part I: angiogenic cytokines. Circulation 2004; 109: 2487-2491.
52. Akhyari P, Fedak PW, Weisel RD, et al. Mechanical stretch regimen enhances the formation of bioengineered autologous cardiac muscle grafts. Circulation 2002, 106 (Suppl 1): 1137-142.
53. Dar A, Shachar M, Leor J, et al. Optimization of cardiac cell seeding and distribution in 3D porous alginate scaffolds. Biotechnol Bioeng 2002; 80: 305-312.
54. Pedrotty DM, Koh J, Davis BH, et al. Engineering skeletal myoblasts: roles of three-dimensional culture and electrical stimulation. Am J Physiol Heart Circ Physiol 2005; 288: H1620-1626.
55. Christman KL, Fok HH, Sievers RE, et al. Fibrin glue alone and skeletal myoblasts in a fibrin scaffold preserve cardiac function after myocardial infarction. Tissue Eng 2004; 10: 403-409.
56. Park H, Radisic M, Lim JO, et al. A novel composite scaffold for cardiac tissue engineering. In vitro Cell Dev Biol Anim 2005; 41: 188-196.
57. Wan WK, Campbell G, Zhang ZF, et al. Optimizing the tensile properties of polyvinyl alcohol hydrogel for the construction of a bioprosthetic heart valve stent. J Biomed Mater Res 2002; 63: 854-861.
58. Dvorin EL, Wylie-Sears J, Kaushal S, et al. Quantitative evaluation of endothelial progenitors and cardiac valve endothelial cells: proliferation and differentiation on poly-glycolic acid/ poly-4-hydroxybutyrate scaffold in response to vascular endothelial growth factor and transforming growth factor b1. Tissue Eng 2003; 9: 487-493.
59. Alperin C, Zandstra PW, Woodhouse KA. Polyurethane films seeded with embryonic stem cell-derived cardiomyocytes for use in cardiac tissue engineering applications. Biomaterials 2005; 26: 7377-86.
60. Shin M, Ishii O, Sueda T, et al. Contractile cardiac grafts using a novel nanofibrous mesh. Biomaterials 2004; 25: 3717-23.
61. Pego AP, Siebum B, Van Luyn MJ, et al. Preparation of degradable porous structures based on 1.3-trimethylene carbonate and D,L-lactide (co)polymers for heart tissue engineering. Tissue Eng 2003; 9: 981-994.
62. Meyer GP, Wollert KC, Lotz J, et al. Intracoronary bone marrow cell transfer after myocardial infarction: eighteen months' follow-up data from the randomized, controlled BOOST (BOne marrOw transfer to enhance ST-elevation infarct regeneration) trial. Circulation 2006; 113: 1287-1294.
63. Janssens S, Dubois C, Bogaert J, et al. Autologous bone marrow-derived stem-cell transfer in patients with ST-segment elevation myocardial infarction: double-blind, randomised controlled trial. Lancet 2006; 367: 113-21.
64. Lunde K, Solheim S, Aakhus S, et al. Intracoronary injection of mononuclear bone marrow cells in acute myocardial infarction. N Engl J Med 2006; 355: 1199-209.
65. Schwartz RS. The politics and promise of stem-cell research. N Engl J Med 2006; 355: 1189-91.